Entera Bio annual operating margin
2018
2019
2020
2021
2022
2024
2025
Entera Bio's operating margin was −27,450.00% for fiscal 2025.
View full Entera Bio company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −27,450.00% | −22154.42 pp |
| 2024 | 2024-12-31 | −5,295.58% | +4418.60 pp |
| 2022 | 2022-12-31 | −9,714.18% | −7574.60 pp |
| 2021 | 2021-12-31 | −2,139.58% | +920.15 pp |
| 2020 | 2020-12-31 | −3,059.73% | +1793.66 pp |
| 2019 | 2019-12-31 | −4,853.39% | −2681.19 pp |
| 2018 | 2018-12-31 | −2,172.20% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −6,102.38% | +15811.90 pp |
| Q4 2024 | 2024-12-31 | −2,850.00% | +32962.50 pp |
| Q3 2024 | 2024-09-30 | −7,192.86% | +191.23 pp |
| Q2 2024 | 2024-06-30 | −3,798.25% | +1841.46 pp |
| Q4 2022 | 2022-12-31 | −21,914.29% | −19436.71 pp |
| Q3 2022 | 2022-09-30 | −35,812.50% | −33512.50 pp |
| Q2 2022 | 2022-06-30 | −7,384.09% | −5026.29 pp |
| Q1 2022 | 2022-03-31 | −5,639.71% | −4149.90 pp |
| Q4 2021 | 2021-12-31 | −2,477.58% | +4305.12 pp |
| Q3 2021 | 2021-09-30 | −2,300.00% | +441.89 pp |
| Q2 2021 | 2021-06-30 | −2,357.80% | — |
| Q1 2021 | 2021-03-31 | −1,489.81% | — |
| Q2 2020 | 2020-06-30 | −6,782.69% | — |
| Q2 2019 | 2019-06-30 | −2,741.89% | — |
Over the last five reported fiscal years, Entera Bio's operating margin decreased from −4,853.39% to −27,450.00%, a change of −22596.61 percentage points. The latest reported quarter, Q1 2025, shows −6,102.38%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio filings at SEC.gov ↗